In current studies we did not find any negative correlation between the expression level of SHP and cyclin D1 in fibrolamellar carcinoma, which may suggest additional mode of action of SHP on hepatocarcinogenesis other than regulation of the cell cycle through this particular cell cycle regulator. Here, NR0B2 is linked to fibrolamellar hepatocellular carcinoma.